Balance Labs Inc
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries improve and fine-tune their business models, sales and marketing plans, and internal operations, as well as make introductions to prof… Read more
Balance Labs Inc (BLNC) - Total Liabilities
Latest total liabilities as of September 2025: $8.73 Million USD
Based on the latest financial reports, Balance Labs Inc (BLNC) has total liabilities worth $8.73 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Balance Labs Inc - Total Liabilities Trend (2014–2024)
This chart illustrates how Balance Labs Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Balance Labs Inc Competitors by Total Liabilities
The table below lists competitors of Balance Labs Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA
|
USA | $5.55 Million |
|
Eugene Special Purpose Acquisitions 4 Company
KQ:321260
|
Korea | ₩4.60 Billion |
|
Roadman Investments Corp
V:LITT
|
Canada | CA$1.95 Million |
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
USA | $2.52 Million |
|
Bannari Amman Spinning Mills Limited
NSE:BASML
|
India | ₹5.42 Billion |
|
Tao Heung Holdings Limited
F:BVI
|
Germany | €731.95 Million |
|
PharmaCyte Biotech Inc
NASDAQ:PMCB
|
USA | $19.42 Million |
|
Tenon Medical Inc
NASDAQ:TNON
|
USA | $5.57 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Balance Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 164.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Balance Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Balance Labs Inc (2014–2024)
The table below shows the annual total liabilities of Balance Labs Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.17 Million | +8.46% |
| 2023-12-31 | $4.76 Million | +3.77% |
| 2022-12-31 | $4.59 Million | +4.15% |
| 2021-12-31 | $4.41 Million | +14.25% |
| 2020-12-31 | $3.86 Million | +21.49% |
| 2019-12-31 | $3.18 Million | +30.79% |
| 2018-12-31 | $2.43 Million | +47.50% |
| 2017-12-31 | $1.65 Million | +98.55% |
| 2016-12-31 | $829.05K | +212.77% |
| 2015-12-31 | $265.06K | +262.58% |
| 2014-12-31 | $73.11K | -- |